Mizuho Maintains Buy on Haemonetics, Raises Price Target to $100

Mizuho analyst Anthony Petrone maintains Haemonetics (NYSE:HAE) with a Buy and raises the price target from $90 to $100.

Mizuho analyst Anthony Petrone maintains Haemonetics (NYSE:HAE) with a Buy and raises the price target from $90 to $100.

Total
0
Shares
Related Posts